Results
1 -
10 of
397
(Click
here to explore results)
- Investigating the complexation propensity of self-assembling dipeptides with the anticancer peptide-drug Bortezomib: a computational study. Peter Divanach, Eirini Fanouraki, Anna Mitraki, Vagelis Harmandaris, Anastassia N. Rissanou
, Soft Matter
, 2023
, 19
, 8684
- Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi. Vilmos Csizmadia, Paul Hales, Christopher Tsu, Jingya Ma, Jiejin Chen, Pooja Shah, Paul Fleming, Joseph J. Senn, Vivek J. Kadambi, Larry Dick, Francis S. Wolenski
, Toxicol. Res.
, 2016
, 5
, 1619
- MicroC3: an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Chorom Pak, Natalie S. Callander, Edmond W. K. Young, Benjamin Titz, KyungMann Kim, Sandeep Saha, Kenny Chng, Fotis Asimakopoulos, David J. Beebe, Shigeki Miyamoto
, Integr. Biol.
, 2015
, 7
, 643
- A quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs. Choong Kim, Junichi Kasuya, Jessie Jeon, Seok Chung, Roger D. Kamm
, Lab Chip
, 2015
, 15
, 301
- Supercritical fluid (CO2) chromatography for quantitative determination of selected cancer therapeutic drugs in the prescence of potential impurities in injection formulations. Venkata Narasimha Rao G., Ravi B., Jalandhar D., Manoj P., R. Venkata Nadh
, Anal. Methods
, 2017
, 9
, 3003
- Bortezomib-loaded immunoliposomes against CD44 expressing macrophages: an interplay for inflammation resolution. Simran Nasra, Haly Shukla, Milonee Patel, Ashutosh Kumar
, Nanoscale
, 2024
, 16
, 5280
- An efficient 2D 11B–11B solid-state NMR spectroscopy strategy for monitoring covalent self-assembly of boronic acid-derived compounds: the transformation and unique architecture of bortezomib molecules in the solid state. J. Brus, J. Czernek, M. Urbanova, L. Kobera, A. Jegorov
, Phys. Chem. Chem. Phys.
, 2017
, 19
, 487
- Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer. Kaiqi Wu, Ru Cheng, Jian Zhang, Fenghua Meng, Chao Deng, Zhiyuan Zhong
, J. Mater. Chem. B
, 2017
, 5
, 5658
- Oxathiazole-2-one derivative of bortezomib: Synthesis, stability and proteasome inhibition activity. Berkley E. Gryder, Will Guerrant, Chin Ho Chen, Adegboyega K. Oyelere
, Med. Chem. Commun.
, 2011
, 2
, 1083
- Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration. M. De Santo, A. Giovinazzo, M. Fava, E. Mazzotta, I. E. De Napoli, M. Greco, A. Comandé, A. Nigro, P. Argurio, I. Perrotta, M. Davoli, A. Tagarelli, R. Elliani, T. Granato, G. Nicolini, A. Chiorazzi, S. Semperboni, E. Ballarini, C. Crocamo, G. Cavaletti, D. Lombardo, D. Sisci, C. Morelli, A. Leggio, L. Pasqua
, Mater. Chem. Front.
, 2023
, 7
, 216